Skip to main content

letter

. 1981 Mar 21;282(6268):985–986. doi: 10.1136/bmj.282.6268.985-c

Levodopa: long-term impact on Parkinson's disease.

D M Mann, P O Yates

PMCID: PMC1504814 PMID: 6781685

985

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Lesser R. P., Fahn S., Snider S. R., Cote L. J., Isgreen W. P., Barrett R. E. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 1979 Sep;29(9 Pt 1):1253–1260. doi: 10.1212/wnl.29.9_part_1.1253. [DOI] [PubMed] [Google Scholar]
Mann D. M., Yates P. O., Barton C. M. Neuromelanin and RNA in cells of substantia nigra. J Neuropathol Exp Neurol. 1977 Mar-Apr;36(2):379–383. doi: 10.1097/00005072-197703000-00012. [DOI] [PubMed] [Google Scholar]
Mann D. M., Yates P. O., Barton C. M. Variations in melanin content with age in the human substantia nigra. Biochem Exp Biol. 1977;13(2):137–139. [PubMed] [Google Scholar]
Mann D. M., Yates P. O. Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain. 1974 Sep;97(3):489–498. doi: 10.1093/brain/97.1.489. [DOI] [PubMed] [Google Scholar]
Shaw K. M., Lees A. J., Stern G. M. The impact of treatment with levodopa on Parkinson's disease. Q J Med. 1980;49(195):283–293. [PubMed] [Google Scholar]

ACTIONS

RESOURCES